Search results for: 'service revenue model'
- Did you mean
- service revenue m9de
- service revenue m8de
- Related search terms
- Services 2.0: The New Business Frontier for Profitability
- model spectrometri market global 2030 2024
- model spectrometri market global 2022 2024
- model spectrometry market global 2030 2024
- model spectrometry market global 2022 2024
-
03 Feb 2023  |  North America  |  Market Research
Global Pharmaceutical Continuous Manufacturing Market, Growth Opportunities
Regulatory Acceptance Propelling Continuous Manufacturing Investments through Partnerships and In-house Expansions
Continuous manufacturing (CM) is a method for manufacturing end-to-end pharmaceutical products on a single, uninterrupted production line. While batch manufacturing requires transporting, testing, and refeeding materials from one process to the next, continuous processes execute all testing, feeding, and processing inline at a single manufacturing ...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 Apr 2023  |  Asia Pacific  |  Market Outlook
Asia-Pacific Pharmaceutical Industry Outlook, 2023
Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry
Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...
$4,950.00
Special Price $3,712.50 save 25 %
-
29 Jun 2018  |  Global  |  Technology Research
Novel Therapies for Rare and Genetic Diseases
Unveiling One of the Most Promising Fields of Therapeutic Technology Synergy
Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...
$4,950.00
Special Price $3,712.50 save 25 %
-
26 Nov 2021  |  Europe  |  Market Research
EU COVID-19 Vaccine and Therapeutics Insights, Trends, and Growth Opportunities
Future Growth Potential Driven by Capabilities and Expertise in Vaccine Manufacturing
With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly, t...
$2,450.00
Special Price $1,837.50 save 25 %
-
16 Nov 2022  |  North America  |  Frost Radar
Frost Radar™: Cell and Gene Therapy Contract Development and Manufacturing Organizations, 2022
A Benchmarking System to Spark Companies to Action-Innovation that Fuels New Deal Flow and Growth Pipelines
As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contract research organizations (CROs) can play a critical role in long-term genetic analysis and monitor safety and efficacy up to 15 years after treat...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Aug 2021  |  North America  |  Market Research
US and EU Biotech Industry VC Investment Growth Opportunities
Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI
With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...
$2,450.00
Special Price $1,837.50 save 25 %
-
19 Aug 2022  |  North America  |  Market Research
Global Antibody Therapeutics Growth Opportunities
The Evolution of Next-generation Immuno-oncology Therapies for Multiple Tumor Antigens is Poised to Drive Market Growth
Market growth is likely to be fueled by the growing utilization of cost-effective and efficient continuous manufacturing processes and single-use bioreactors for production, which will also reduce the time between development and commercialization. Favorable regulatory reforms in emerging Asian countries are encouraging the manufacture and introduc...
$2,450.00
Special Price $1,837.50 save 25 %
-
28 Apr 2020  |  Global  |  Technology Research
Breakthrough Innovations Enhancing Gut Microbial Health
Empowering Medical, Academic and Industrial Communities Through Expert Advice Across Multiple Scientific Disciplines
Overall Impact of Breakthrough Innovations in Gut Microbial Health Covered in this Research - Microbiome expertise: Meeting translational research needs from medical, academic and industrial communities through deep diving know-how and expertise across multiple scientific platforms - Nutrition and therapeutic fields: Enabling precision medicine an...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Feb 2021  |  North America  |  Market Research
Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market
High Unmet Needs in Niche Oncology Indications will Drive Future Growth Potential
Frost & Sullivans Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and c...
$2,450.00
Special Price $1,837.50 save 25 %
-
27 Aug 2020  |  Global  |  Market Research
Smart Labs as Key Drivers for the Digital Transformation of Diagnostic Laboratories, 2020
Robotic Automation, Internet of Things (IoT), and Artificial Intelligence (AI) Offering Growth Opportunities for Academic and Commercial Diagnostics Labs
Diagnostic academic and commercial research labs suffer from cost pressures, given the ongoing Protecting Access to Medicare Act (PAMA) regulations and reproducibility issues, and are under productivity strain. The recent COVID-19 pandemic leading to increasing test volumes and renewed focus on research and development (R&D) to drive innovation wil...
$3,000.00
Special Price $2,250.00 save 25 %